1. Home
  2. SABS vs OST Comparison

SABS vs OST Comparison

Compare SABS & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • OST
  • Stock Information
  • Founded
  • SABS 2014
  • OST 2010
  • Country
  • SABS United States
  • OST China
  • Employees
  • SABS N/A
  • OST N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • SABS Health Care
  • OST Technology
  • Exchange
  • SABS Nasdaq
  • OST Nasdaq
  • Market Cap
  • SABS 15.8M
  • OST 15.7M
  • IPO Year
  • SABS N/A
  • OST 2022
  • Fundamental
  • Price
  • SABS $2.28
  • OST $1.66
  • Analyst Decision
  • SABS Strong Buy
  • OST
  • Analyst Count
  • SABS 5
  • OST 0
  • Target Price
  • SABS $10.00
  • OST N/A
  • AVG Volume (30 Days)
  • SABS 85.9K
  • OST 185.8K
  • Earning Date
  • SABS 11-05-2025
  • OST 09-19-2025
  • Dividend Yield
  • SABS N/A
  • OST N/A
  • EPS Growth
  • SABS N/A
  • OST N/A
  • EPS
  • SABS N/A
  • OST N/A
  • Revenue
  • SABS $114,698.00
  • OST $38,333,251.00
  • Revenue This Year
  • SABS N/A
  • OST N/A
  • Revenue Next Year
  • SABS N/A
  • OST N/A
  • P/E Ratio
  • SABS N/A
  • OST N/A
  • Revenue Growth
  • SABS N/A
  • OST 0.34
  • 52 Week Low
  • SABS $1.00
  • OST $1.35
  • 52 Week High
  • SABS $6.60
  • OST $235.00
  • Technical
  • Relative Strength Index (RSI)
  • SABS 54.42
  • OST 26.79
  • Support Level
  • SABS $2.03
  • OST $1.50
  • Resistance Level
  • SABS $2.34
  • OST $2.07
  • Average True Range (ATR)
  • SABS 0.12
  • OST 0.23
  • MACD
  • SABS 0.02
  • OST 1.49
  • Stochastic Oscillator
  • SABS 84.00
  • OST 19.14

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: